CD19 and neoplasm: To our knowledge, only two in vitro reports have described the deleterious effect of GCs on CAR T cells: They reported that GCs, in a dose-dependent manner, to reduce CD19-CAR T cells proliferation and their killing activity against different tumor cells [17].